By Nina Agrawal Health Secretary Robert F. Kennedy Jr. has repeatedly questioned the safety of mRNA vaccines against Covid-19. Scientists with funding from the National Institutes of Health were ...

Therapies involving mRNA, a key to Covid vaccines, hold great potential in treating several diseases, but some lawmakers want to ban them and the government is cutting funding. By Kate Zernike To ...

After the remarkable success of the mRNA vaccines in protecting people against COVID-19, scientists are turning their attention next to another annual respiratory scourge: influenza. Both Moderna ...

Federal support for mRNA vaccine research appears in jeopardy after KFF Health News reported Sunday that officials at the National Institutes of Health have directed scientists to remove all ...

Moderna (MRNA) stock is climbing 8% after the drug maker won a key court case and its CEO bought shares on the open market. MRNA's Court Victory A German court ruled that BioNTech (BNTX ...

SHANGHAI/SUZHOU, China, April 19 (Reuters) - China's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA ...

A safety analysis of mRNA vaccination in a phase 1, randomized, open-label clinical trial evaluated the safety and tolerability of three investigational HIV-1 trimer mRNA vaccines. The study ...

Phil Santangelo has developed a treatment for dengue virus using mRNA and CRISPR technology. Phil Santangelo has led development of a new treatment for dengue virus, using mRNA and CRISPR technology. ...

A June 9 Instagram post (direct link, archive link) shows excerpts from a document that makes claims about mRNA COVID-19 vaccines. "We conclude that the mRNA vacs dramatically increase ...

uses a powerful monitoring system to reveal how the human immune system is responsive to a litany of tick triggers — some of which might be leveraged to create a protective mRNA vaccine.

The first mRNA mpox vaccine to be pitted against licensed vaccines beat its rivals by easing symptoms and potentially cutting transmission, according to new research published Tuesday, a coup for ...

As many as 10,000 cancer patients in the U.K. will be treated with personalized mRNA cancer treatments by 2030, BioNTech said in a statement, whether as part of a clinical trial testing the new ...